$92.19 1.3%
Price vs. AI Score (Last 150 days)
Data gathered: December 1

Data Bits

Data Bits Value / Change Benchmark
Job Posts 117 -3.3%
Sentiment 86 -1.1%
Webpage traffic 41,000 43.9%
Employee Rating 83 0%
Google Adspend $2,306 692.4%
Google Trends 0%
Linkedin Employees 3,239 N/A
Patents 73 0%
4chan Mentions 0%
Facebook Engagement 3 50%
Facebook followers 6,038 0%
Stocktwits Mentions 2 100%
Stocktwits Subscribers 5,037 -0.1%
Youtube Subscribers 1,330 0%
Instagram Followers 4,219 N/A N/A
News Mentions -100%
Reddit Mentions 0%
Business outlook 79 0%

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

In the news

About Biomarin Pharmaceutical

BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions.

Biomarin Pharmaceutical
Price $92.19
Target Price Sign up
Market Cap $16.9B
Dividend Yield 0.0371
Industry Biotechnology

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda
Q3 '23578M125M453M40M71M
Q2 '23592M128M463M56M100M
Q1 '23586M127M460M51M87M
Q4 '22506M127M379M-250,00011M
Q3 '22501M116M384M-6.7M28M

Insider Transactions

Ajer Jeffrey Robert filed to sell 60,804 shares at $90.
August 17 '23
FUCHS HENRY J filed to sell 176,187 shares at $90.4.
August 11 '23
Guyer Charles Greg filed to sell 40,041 shares at $93.3.
August 10 '23
BIENAIME JEAN JACQUES filed to sell 422,732 shares at $88.3.
August 9 '23
Davis George Eric filed to sell 69,474 shares at $89.4.
August 9 '23
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2023 AltIndex. All rights reserved.